Consistently, T47D breast cancer cells with the H1047R mutation in PIK3CA were sensitive to the p110α inhibitor BYL719 measured by cell viability assay, but exhibited a lower response when PTEN was knocked down [15]. This evidence concerns the gene PIK3CA and breast carcinoma.